FDAFDA · Food and drugs·Recall number D-1546-2022
ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01
Published October 5, 2022 · Recall initiated: August 23, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CLOMIPRAMINE HYDROCHLORIDE
- Manufacturer
- Leading Pharma, LLC
- Distributor
- Nationwide within the United States
- UPC
- 0369315167014
- Lot
- Lot#: B14221, Exp. Date 02/2023
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.